key: cord-0853390-27l6ps4l
authors: Mundae, Rusdeep; Wagley, Sushant; Ryan, Edwin H.; Parke, D.Wilkin; Mittra, Robert A.; Tang, Peter H.
title: COVID-19 vaccination hesitancy and its association with altered presentation of primary rhegmatogenous retinal detachment
date: 2022-05-21
journal: Am J Ophthalmol
DOI: 10.1016/j.ajo.2022.05.013
sha: bee51c2fe7282a4498a9019bf11e2cd5888f0efd
doc_id: 853390
cord_uid: 27l6ps4l

Purpose : Evaluate factors associated with coronavirus 2019 (COVID-19) vaccine hesitancy and clinical trends in primary rhegmatogenous retinal detachments (RRD) during first year of vaccine availability. Design : Single-center, clinical cohort study Methods : Consecutive patients from December 14, 2020 to December 12, 2021 presenting vaccinated (Prior-), subsequently vaccinated (Later-), or remaining unvaccinated (Never-Vax). Primary outcome was proportion with macula-off (mac-off) RRD. Secondary outcomes included logarithm of the minimum angle of resolution (logMAR) best-corrected visual acuity (BCVA), primary proliferative vitreoretinopathy (PVR), proportion lost to follow-up, and distance traveled. Results : 1,047 patients were divided into 391 Prior-, 252 Later-, and 404 Never-Vax cohorts. Significantly greater proportion of Later- and Never-Vax cohorts presented with mac-off RRDs (Prior-Vax = 44.5%; Later-Vax = 54%, P < 0.0001; Never-Vax = 57.9%, P < 0.0001) and primary PVR (Prior-Vax = 4.3%; Later-Vax = 13.6%, P < 0.0001; Never-Vax = 17.1%, P < 0.0001) compared to Prior-Vax cohort. Significantly greater proportion of Never-Vax cohort (7.7%, P < 0.0001) were lost to follow-up compared to Prior- (2.3%) and Later-Vax (2.2%) cohorts. Never-Vax cohort (median = 35 miles) traveled further compared to Prior- (median = 22.3 miles; P < 0.0001) and Later-Vax cohorts (25.45 miles; P = 0.0038). Prior-Vax cohort had significantly better (P < 0.05) initial (median = 0.30 logMAR) and final (0.18 logMAR) BCVA compared to Later- (Initial: 0.54 logMAR; Final: 0.30 logMAR) and Never-vax (Initial: 0.70 logMAR; Final: 0.40 logMAR) cohorts. Conclusions : COVID-19 vaccine hesitancy is associated with worse clinical presentation and outcomes for primary RRD.

Methods: Consecutive patients from December 14, 2020 to December 12, 2021 presenting vaccinated (Prior-), subsequently vaccinated (Later-), or remaining unvaccinated (Never-Vax).

Primary outcome was proportion with macula-off (mac-off) RRD Conclusions: COVID-19 vaccine hesitancy is associated with worse clinical presentation and outcomes for primary RRD.

Primary rhegmatogenous retinal detachment (RRD) is an urgent medical condition and typically warrants prompt surgical intervention, especially if the subretinal fluid (SRF) spares the macula (mac-on). 1, 2 Progression to involve the fovea (mac-off) has been shown to result in worse visual outcomes even after successful surgical repair. 1 Previous studies highlighted a significant delay in intervention of urgent and emergent ophthalmic diseases such as RRD during the coronavirus disease 2019 (COVID-19) pandemic due to challenges posed by a decline in healthcare access, socioeconomic hardship, and general anxiety. [3] [4] [5] [6] [7] [8] This has prompted the development of safe and effective COVID-19 vaccines with the aim of suppressing the virus and restoring social and economic normality. 11 ). While the initial scarcity of vaccines necessitated a phased approach to prioritize essential personnel and high-risk populations, vaccination of the general US population began on March 30, 2021 once supply became more readily available. 12 Subsequently, the age limit for the Pfizer vaccine was expanded to include children ages 5 to 15. Vaccine hesitancy, defined by the World Health Organization (WHO) as a delay or refusal of immunization when it is available and is considered a top 10 threat to global health. 13 With the general anxiety brought about by the pandemic, numerous studies have shown a delay in ophthalmic care and worse clinical outcomes for patients with ophthalmic emergencies such as RRDs. [5] [6] [7] [8] Our aim was to evaluate and describe the factors associated with COVID-19 vaccine hesitancy and the clinical trends for primary RRDs at presentation, treatment course, and clinical outcomes in the Upper Midwest region of the US during the first full year after the vaccines became available. Patients were considered vaccinated after a single dose of J&J vaccine or at least one dose of Pfizer or Moderna vaccine. Vaccination status was noted as "Prior-Vax" if patients were vaccinated prior to initial presentation. Those unvaccinated at initial presentation were separated into "Later-Vax" or "Never-Vax" cohorts depending on if they received vaccination or remained unvaccinated during post-operative course, respectively. Prior-Vax status was confirmed with perioperative records. Later-and Never-Vax statuses were self-reported and confirmed with documentation when available. Patients who had a documented contraindication to receiving vaccination at the time of initial presentation were excluded. Furthermore, those who presented unvaccinated prior to and without a follow-up appointment after March 30, 2021 (when eligibility was expanded to general population) were excluded due to unknown Later-or Never-Vax status. Demographic, preoperative, intraoperative, and follow-up data were collected. Race was self-identified as "Caucasian", "Black", "Asian", "Native American", "Hispanic", "Decline to Specify", or "Other". Median household income was used as a quantitative surrogate for socioeconomic status tabulated from American Communities Survey 2017 of median income by the patient home zip code. 6, 8, 15 Patients were considered "established" if previously seen within a 3-year period before diagnosis; otherwise, they were considered "new". Distance from patient home zip code to clinic was used as a quantitative surrogate for healthcare access and was calculated based on the shortest route (miles) using Google Maps (Alphabet, Inc., Mountain View, CA). Time between initial diagnosis and surgery was recorded. Initial Snellen bestcorrected visual acuity (BCVA) was obtained from visit where patient was diagnosed by. Final BCVA was determined at latest post-operative visit; however, those with a follow-up course less than 3-months were excluded.

Primary outcome was proportion of vaccinated versus unvaccinated patients demonstrating mac-on RRD, as opposed to mac-off RRD (defined as foveal detachment) on preoperative evaluation. Secondary outcomes include initial and final BCVA, proportion with symptom duration of 1 day or less, mean duration of symptoms, time to surgical repair, and presence of grade C or higher primary proliferative vitreoretinopathy (PVR).

Statistical analysis was performed on JMP software (SAS Institute, Cary, NC). Snellen BCVA was converted to logarithm of the minimum angle of resolution (logMAR) units for quantitative analysis, with logMAR values for BCVA of "light perception", "hand motion", and "counting fingers" assigned 2.7, 2.3, and 1.8, respectively. 16 Comparison of categorical variables between two cohorts was completed using a 2-tailed Fisher exact test. Continuous quantitative variables including age, median household income, travel distance, duration of symptoms, time to surgery, and logMAR BCVA were found to be non-normal using the Shapiro-Wilk test. The Median test, utilizing median rank scores, was used for comparisons involving travel distance and logMAR BCVA. All other non-normal distributions were compared using the Mann-Whitney U test. P-value < 0.05 was considered statistically significant.

Our study population was divided into cohorts based on COVID-19 vaccination status, defined as receiving at least 1 dose of Pfizer or Moderna vaccines or single-dose J&J vaccine.

Querying the billing data for CPT codes generated 1,462 procedures for the year. After excluding patients without rhegmatogenous etiology, total of 1,047 patients were analyzed.

Various baseline characteristics described in Table 1 were found to be similar between Prior-, Later-, and Never-Vax cohorts; however, there was a significantly (P = 0.0487) lower proportion of Never-Vax patients who presented within 1 day of symptoms onset (6.9%) compared to Prior-Vax patients (10%). Vaccination rate for the group as a whole was below that reported by the Minnesota Department of Health (MDH; Figure 1 , A). 17 proportion of patients presenting with retinal re-detachments following initial surgical repair (Later-Vax = 7.4%; Never-Vax = 13.5%) compared to the Prior-Vax cohort (5.9%; Figure 2 , B).

Both Later-and Never-Vax cohorts demonstrated significantly higher (P < 0.0001) rates of patients with primary mac-off RRDs (Later-Vax = 54%; Never-Vax = 57.9%) compared to the Prior-Vax cohort (44.5%; Figure 2 , C). Furthermore, the presence of primary PVR was found to be significantly greater (P < 0.0001) in both Later-(13.6%) and Never-Vax (17.1%) cohorts compared to the Prior-Vax cohort (4.3%; Figure 2 , D).

Postoperative follow-up data were collected for all patients who underwent surgical repair of primary RRD. When examining follow-up duration, approximately 12% of Prior-, 9.1% of Later-, and 19.1% of Never-Vax cohorts did not present for a 3-month or later appointment.

Patients who were referred back to their referring provider prior to the 3-month timepoint for 

The Later-and Never-Vax cohorts presented with significantly worse (P ≤ 0.0006) initial and final BCVA compared to the Prior-Vax cohort ( Figure 6 , A). There were no significant differences (P = 0.1422) in initial and final BCVA between Later-and Never-Vax cohorts. This trend persisted when analyzing patients with mac-off disease (Figure 6 , B) and those new to our clinic ( Figure 6 , C).

Multiple factors affect the development of mac-off disease in the setting of primary RRD including pseudophakia, site of retinal break(s), degree of vitreous liquefaction, bullous configuration, axial length, and age. 1, 2 Socioeconomic and demographic statuses are implicated as important risk factors for decreased surgical success and worse clinical outcomes. [22] [23] [24] The pandemic has further exacerbated these pre-existing factors. 5-8 Based on our PubMed/Medline database search, we believe this is the first study to investigate whether COVID-19 vaccine hesitancy has broader implications for clinical trends in emergent ophthalmic conditions. Our findings suggest that patients who are proactive in obtaining vaccination are less likely to suffer significant RRD disease and have better clinical outcomes. This may be facilitated by a higher degree of medical compliance due to decreased pandemic-related fear and anxiety, as suggested by lower rates of hospitalization and death from COVID-19 infection when compared to the unvaccinated. 25, 26 Even though our clinics are based in major metropolitan regions within Minnesota, we do treat a significant amount of rural and out-of-state patients. Previous studies have shown that rural and lower socioeconomic communities exhibit greater COVID-19 vaccine hesitancy. [27] [28] [29] [30] As such, the vaccination rate for our study population was lower than that reported by MDH. The lowest rate was observed in patients presenting to our St. Cloud office, which is reflective of lower vaccination rates locally and from North and South Dakota patients traveling for care to this clinic. Patients presenting to our MSP offices had a lower vaccination rate compared to our Duluth office, likely due to the availability of our MSP offices for emergent after-hours appointments.

Vaccine hesitancy is defined by the WHO as a delay or refusal of immunization when it is available. 13 We labeled a patient as vaccine hesitant if he or she initially presented unvaccinated and remained so throughout their postoperative course lasting a minimum of 3 months. Since we analyzed clinical trends for a full year after the availability of COVID-19 vaccines, we observed a significant increase in vaccine hesitancy during the latter half of the year. A likely explanation is that initial vaccine scarcity meant a significant portion of patients presenting unvaccinated earlier in the year had the intention to get the vaccine but lacked access.

Once supply became more plentiful, they were able to vaccinate during their postoperative course. As access to vaccines became less of a barrier later in the year, unvaccinated patients were more likely to exhibit vaccine hesitancy due to a variety of reasons such as distrust of the medical field and belief in misinformation. 28, 29 The presence of primary PVR is a poor prognostic factor associated with delayed presentation. 31 Primary RRD patients who were initially unvaccinated for COVID-19 demonstrated more advanced retinal pathology such as mac-off status and primary PVR, the highest of which was observed in vaccine hesitant patients. The result was a greater number of complex surgical interventions and increased retinal re-detachments requiring repeat surgeries.

Interestingly, this trend was only observed in patients who were new to our clinic, as established patients had similar rates of mac-off disease.

Studies have shown that COVID-19 vaccination rates are much lower in younger populations, likely due to lower perceived seriousness of infection by this age group. 32, 33 Data reported by MDH also supports this, where patients in the age categories of 65 and older, 50 to 64 years, and 18 to 49 years were vaccinated at a rate of 97%, 79%, and 69% by our study endpoint. 17 We observed highest rates of vaccinated patients in older groups with a subsequent decline in younger groups. Conversely, the proportion of vaccine hesitant patients appeared to increase in younger groups. We also observed a higher proportion of older patients present with mac-off RRD; however, this is likely related to ocular features of advanced age (i.e. presence of a posterior vitreous detachment, increased vitreous liquefaction, etc) 1, 2 instead of a direct effect from vaccines.

It has been well documented that people living in rural areas are less likely to undergo COVID-19 vaccination. 34, 35 We utilized the distance traveled by patients for care as a surrogate for healthcare access. We found that patients who traveled the furthest for care tended to be vaccine hesitant, especially those that were new to our clinic. Poorer access to ophthalmic care certainly contributed to more advanced disease amongst this population. The end result was that vaccinated patients presented with significantly better BCVA and had improved clinical outcomes compared to those who initially presented unvaccinated.

There were several important limitations to our study. Due to its retrospective nature, there was inherent confirmation bias. Vaccination status after surgery relied on patient selfreporting, but verification by our clinic staff was attempted. It is possible that patients who we considered vaccine hesitant may have obtained vaccination after the postoperative period with our practice; however, this delay in vaccination still conforms to the definition of vaccine hesitancy by the WHO. 13 We are unable to further verify vaccination status afterwards as we lack access to their general medical information. The parameters by which we established the various vaccination cohorts for analysis are artificial and do not reflect nuances in rationale used by individual patients when deciding whether to undergo vaccination. It is conceivable that vaccines could modify an individual's ocular response to an insult such as RRD; however, this was not explicitly investigated. As the majority of our patient population is Caucasian with a median household income higher than national median, this limits the applicability of our results across various racial and socioeconomic groups. Our geographical area may additionally limit the broader applicability of this study. Furthermore, rates of COVID-19 vaccinations and degrees of public health measures taken by local governments varied greatly, limiting extrapolation of our data to other regions of the country. Timing of surgery after diagnosis of RRD did not differ between cohorts, indicating vaccination status did not affect patient access to surgery. Variations in RRD presentation due to factors such as seasonal weather patterns and holidays may have influenced our clinical trends reported.

At the conclusion of this study, only 70.2% of the US population has received at least one dose of the COVID-19 vaccines. 12 Factors associated with vaccine hesitancy are numerous and may have implications for other ocular diseases such as diabetic retinopathy and glaucoma. We must take these associations into consideration when treating vaccine hesitant patients as they often present with more advanced disease and suffer worse clinical outcomes.

Peter Tang is an associate at VitreoRetinal Surgery, PLLC and an Adjunct Assistant Professor in the Department of Ophthalmology & Visual Neurosciences at the University of Minnesota. He completed a BA from the University of Pennsylvania as well as a combined MD/PhD program from the Medical University of South Carolina. He underwent Ophthalmology residency training at the University of Minnesota followed by a fellowship in Vitreoretinal Surgery and Ocular Oncology at the Byers Eye Institute at Stanford University.

Rusdeep Mundae is an ophthalmology resident at the University of Minnesota. He obtained his BS in Neuroscience from University of California, Los Angeles (UCLA) and his MD from Saint Louis University School of Medicine. He completed his preliminary year in internal medicine at Rush University Medical Center. He has interests in retinal imaging, machine learning/AI, and ophthalmic technology and innovation.

Characteristics were similar between all three vaccination cohorts (Prior-Vax = patients who initially presented for care already vaccinated for COVID-19; Later-Vax = patients who initially presented unvaccinated but subsequently received vaccination during their post-operative course;

Never-Vax = patients who initially presented unvaccinated and remained as such throughout their post-operative course); however, significantly (P = 0.0487) fewer Never-Vax patients were observed to present for cares within 1 day of onset of symptoms compared to Prior-Vax patients. rates, analysis of our study population showed the majority to be 50 years of age or older, with an even distribution between those age 65 and older (65+) and those between ages 50 to 64 (A).

Since our study population contained only 5 patients younger than age 18 (age range 11 to 17), they were excluded from further analysis. There was no significant (P = 0. 

Primary rhegmatogenous retinal detachment: risk factors for macular involvement

Risk of progression in macula-on rhegmatogenous retinal detachment

Emergent ophthalmic surgical care at a tertiary referral center during the COVID-19 pandemic

Impact of the coronavirus pandemic on pediatric eye-related emergency department services

Impact of the COVID-19 pandemic on characteristics of retinal detachments: the Canadian experience

Clinical presentation of rhegmatogenous retinal detachment during the COVID-19 pandemic: a historical cohort study

Frequency of urgent or emergent vitreoretinal surgical procedures in the United States during the COVID-19 pandemic

Trends in the clinical presentation of primary rhegmatogenous retinal detachments during the first year of the COVID-19 pandemic

Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine

Efficacy and Safety of the mRNA-1273 SARS-CoV-2 vaccine

Safety and efficacy of single-dose Ad26.COV2.S vaccine against Covid-19

Accessed December 15, 2021. 13. World Health Organization. Ten threats to global health in

Impact and characterization of delayed pan-retinal photocoagulation in proliferative diabetic retinopathy

Visual acuities "hand motion" and "counting fingers" can be quantified with the freiburg visual acuity test

Minnesota Department of Health

Wisconsin Department of Health Services. COVID-19 Summary Data

North Dakota Department of Health. COVID-19 Vaccine Dashboard

State of South Dakota Department of Health

Iowa Department of Public Health. COVID-19 Vaccine Administration Dashboard

Effect of deprivation and ethnicity on primary macula-on retinal detachment repair success rate and clinical outcomes: a study of 568 patients

Sociodemographic factors influencing rhegmatogenous retinal detachment presentation and outcome

Socioeconomic status and delayed presentation in rhegmatogenous retinal detachment

Impact of vaccination on the COVID-19 pandemic in U

COVID-19 cases and hospitalizations by COVID-19 vaccination status and previous COVID-19 diagnosis -California

Rural-urban and within-rural differences in COVID-19 vaccination rates

Sociodemographic determinants of COVID-19 vaccine hesitancy, fear of infection, and protection self-efficacy

COVID-19 vaccine hesitancy: misinformation and perceptions of vaccine safety

Disparities in COVID-19 vaccination coverage between urban and rural counties -United States

European-Vitreo-Retinal-Society-(EVRS)-Retinal-Detachment-Study-Group. Clinical variables associated with failure of retinal detachment repair: the European vitreo-retinal society retinal detachment study report number 4

Disparities in national and state estimates of COVID-19 vaccination receipt and intent to vaccinate by race/ethnicity, income, and age group among adults ≥ 18 years, United States

Individual determinants of COVID-19 vaccine hesitancy

Factors associated with early receipt of COVID-19 vaccination and adherence to second dose in the Veterans Affairs healthcare system

Targeting COVID vaccine hesitancy in rural communities in Tennessee: implications for extending the COVID-19 pandemic in the South. Vaccines (Basel) 2021;9:1279. are new to our clinic (C), both Later-and Never-Vax cohorts showed significantly worse (Later-Vax: P < 0.0001; Never-Vax: P = 0.0003) initial BCVA (Later-Vax: median = 0

20/80; Never-Vax: median = 0.70 logMAR; Snellen equivalent, 20/100) compared to the Prior-Vax cohort (median = 0

While both Later-and Never-Vax cohorts also showed significantly worse (P < 0.0001) final BCVA (Later-Vax: median = 0.30 logMAR; Snellen equivalent, 20/40; Never-Vax: median = 0.40 logMAR; Snellen equivalent, 20/50) compared to the Prior-Vax cohort (median = 0.18 logMAR; Snellen equivalent, 20/30), there was no significant difference